Most CCR5–/– kidney allograft recipients treated with the neutrophil-depleting antibody developed pyelonephritis by day 30 after transplant, although one of the allografts in neutrophil-depleted recipients survived more than 120 days (D. Ueda, data not shown). The gene discussed is CCR5; the disease is pyelonephritis.